precisioncancerconsortium

aiming to make #precisiononcology #cgp the new normal improving access to #clinicaltrials #pharma #consortium likes, shares and retweets not views of members

[precisioncancerconsortium @PCCconsortium]

And a key component of collaboration is having a clear submission route for potential engagement proposals.

We are pleased to announce that the PCC website now contains 3 contact forms for membership enquiries and collaboration proposals. Link below

https://t.co/ZGsuhyINkH

[precisioncancerconsortium @PCCconsortium]

PCC Chair and co-Chair, Nicole St Jean and Gabriele Allegri, will be at the Advancing Precision Medicine Conference, November 1-2 in Philadelphia.
View the agenda via this link.
Ref: PCC-105
https://t.co/nm0rWMXS4V

[precisioncancerconsortium @PCCconsortium]

Access to CGP is limited in Japan. Reimbursement is limited to one test per lifetime.
Listen to the experts from the PCC’s Japan Think Tank discuss this and more here:
PCC-053
https://t.co/gFkNjlgP9h

[precisioncancerconsortium @PCCconsortium]

Members of the PCC convened at ASCO 2024 to showcase completed and ongoing initiatives to PCC member company personnel.

Watch the video on the PCC website:
https://t.co/1pi3lhEVwH

PCC-074

[precisioncancerconsortium @PCCconsortium]

PCC initiates an exciting project with strategy consulting and market intelligence specialists @DeciBio aiming to reveal insights into LBx adoption and find solutions for under-served populations.

Phase 1 complete✅

Find out more via 🔗below
PCC-068
https://t.co/MZOdDmRuxM

[precisioncancerconsortium @PCCconsortium]

Attending #AMPEurope2024 in Madrid?

Visit Booth-21 in the exhibition area to meet PCC members and learn about our ongoing initiatives.

[precisioncancerconsortium @PCCconsortium]

An abstract on the future of biomarkers in cancer therapeutics, covering everything from diagnostic tool to orchestrators of personalized treatment paradigms.

https://t.co/FJAL2fSQ2b

Ref: PCC-058

[precisioncancerconsortium @PCCconsortium]

Clinical research teams manually match patients one-trial-at-a-time, limiting clinical trial enrollment rates significantly.
This video summarizes a PCC- @MassiveBio collaborative project that uses AI to improve trial matching rates.

https://t.co/ZIKuenIBZr

PCC-035

[precisioncancerconsortium @PCCconsortium]

The abstract entitled: “Effect of a novel artificial intelligence (AI) – enabled multi-trial matching system on patient matching using real-world data” is now published on the @ASCO Abstracts portal.

Abstract number e13501

@MassiveBio

Ref: PCC-037

[precisioncancerconsortium @PCCconsortium]

Announcement: 2023 Annual Report is available on the PCC website.

https://t.co/THeWpFlcbG

[precisioncancerconsortium @PCCconsortium]

I am honored to announce that I am stepping into Chair of the PCC for a 1-year term. Huge thanks to outgoing Chair Cecilia Schott and new Vice-Chair Gabriele Allegri. PCC, pts and HCPs are all on this journey together;to make precision oncology and genomic testing the new normal.

[precisioncancerconsortium @PCCconsortium]

In Apr ‘23, I became Chair of the PCC for a 1-year fixed term.I am extremely proud of what PCC achieved across our projects to make precision oncology and comprehensive genomic testing the new normal. I am succeeded as Chair by my friend and colleague Nicole St Jean (GSK).

[precisioncancerconsortium @PCCconsortium]

Information around how NHS England is embarking on a pilot blood test which could help thousands of people receive earlier, more targeted, lung cancer treatments.

Ref: PCC-023 (DoP: April 2024)

https://t.co/FuWnZ0iZR7

[precisioncancerconsortium @PCCconsortium]

A great article detailing how liquid biopsy (LBx) for tumor profiling is increasingly being used, however concerns remain regarding negative results.

PCC-0019 (DoP: April 2024)

https://t.co/TtNJf1iXXr

[precisioncancerconsortium @PCCconsortium]

A great article detailing how liquid biopsy (LBx) for tumor profiling is increasingly being used, however concerns remain regarding negative results.

Ref: PCC-019

https://t.co/TtNJf1jvMZ

[precisioncancerconsortium @PCCconsortium]

April has been designated as the inaugural National Cancer Prevention and Early Detection Month.
This awareness month is a critical step toward reducing the impact of cancer on individuals, families and communities across the U.S.

Ref: PCC-018

https://t.co/LA4yzzRxdb

[precisioncancerconsortium @PCCconsortium]

An interesting article on Nature regarding 275 million new genetic variants identified in the National Institutes of Health’s All of Us Research Program (open access).

https://t.co/ugHyrW8OfU

[precisioncancerconsortium @PCCconsortium]

If you are interested in gaining practical guidance in the interpretation of genomic test results that help inform clinical decision making for patients with cancer, then have a read of this review article on the ACS online library (open access).
🔗 https://t.co/Us31BEYrLd

[precisioncancerconsortium @PCCconsortium]

A great article on Nature summarizing insights from the Cancer in the 100,000 Genomes Project (open access). Findings demonstrate the utility of linking genomic and real-world clinical data to enable survival analysis.
🔗https://t.co/WsecACwTMC

[precisioncancerconsortium @PCCconsortium]

The PCC has just published a series of videos from a May ‘23 Think Tank with prominent German HCPs.

1. Test reimbursement
2. New biomarkers and access to clinical trials
3. When is the right time to test?

The videos are now on the PCC webpage.

https://t.co/slM0Kvf0AD